DHL Supply Chain is expanding its pharmaceutical and medical device distribution network by 40 percent by investing $150 million to bring critical healthcare products closer to trade partners and patients. The company is planning nine new sites by the end of the year and will also invest in new technology as well.
“This expansion allows DHL Supply Chain to continue to deepen the connections between our customers and the patients they serve,” says Scott Cubbler, President of Life Sciences & Healthcare at DHL Supply Chain. “This most recent expansion also helps us leverage differentiated routes to market, driving even greater efficiency and productivity across the supply chain for our customers. With this expansion, DHL Supply Chain will have a total of 30 sites designed to support pharmaceutical, biotech, and medical device companies.”
The sites are fully licensed with temperature controlled space that supports pharmaceutical storage requirements. In addition, the sites also allow for packaging and managed transportation for integrated solutions.
